Nektar Therapeutics has filed a notice of an exempt offering of securities to raise $30 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Nektar Therapeutics is raising up to $30,000,000.00 in new funding. Sources indicate that as part of senior management Director, Jeffrey Ajer played a key role…